Get started
Author

Maria K. Pomponio

Observed names: Maria K Pomponio, Maria Pomponio
Institution: St. Luke's Hospital
ORCID: 0000-0002-5701-9744
Observed ORCID: 0000-0002-5701-9744
OpenAlex ID: A5051207796
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
2019 · Maria K. Pomponio, Luke J. Keele, et al. · Breast Cancer Research and Treatment · 15
Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer
2019 · Maria Pomponio, Luke Keele, et al. · Annals of Surgical Oncology · 12
Auditory Dysfunction After Head Trauma: Causes, Evaluation, and Treatment
2024 · Maria K. Pomponio, Pamela C. Roehm · Current Physical Medicine and Rehabilitation Reports · 8
Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience
2020 · Maria K. Pomponio, Laura Burkbauer, et al. · Journal of Surgical Oncology · 8
Association between interhospital transfer and increased in-hospital mortality in patients with spinal epidural abscesses
2022 · Maria K. Pomponio, Imad S. Khan, et al. · The Spine Journal · 7
Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting
2021 · John H. Kanter, Maria K. Pomponio, et al. · Clinical Neurology and Neurosurgery · 6
Is there an association between body mass index and 21-gene recurrence score?
2020 · Maria Pomponio, Laura Burkbauer, et al. · Surgical Oncology · 6
Thyroglossal Duct Cysts (TGDC) in the Elderly Population: The Role of Conservative Management
2024 · Maria K Pomponio, Keith R Conti, et al. · Cureus · 2
PDF
A Review of Middle Ear Packing Agents
2025 · Maddelyn Lunt, Maria K. Pomponio, et al. · Graduate Medical Scholars Journal
PDF
462 Is Transfer Status Associated With Inpatient Mortality in Patients Transferred for Non-Elective Neurosurgical Diagnoses?
2022 · Imad S. Khan, Maria Pomponio, et al. · Neurosurgery
Response to “Late relapse rates in patients with early‐stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy”
2020 · Laura Burkbauer, Macy Goldbach, et al. · Journal of Surgical Oncology
Does Time to Adjuvant Chemotherapy Affect Outcomes in Patients with Triple Negative Breast Cancer?
2019 · Maria Pomponio, Luke Keele, et al. · Journal of the American College of Surgeons
Routine Use of MRI May Exaggerate Clinical Stage and Indication for Neoadjuvant Chemotherapy for HER2+ Breast Cancer: A Single Institution Experience
2019 · Christopher McGreevy, Maria Pomponio, et al. · Journal of the American College of Surgeons
Neoadjuvant Chemotherapy Does Not Provide Treatment Benefit in Patients with Low Disease Burden
2019 · Maria Pomponio, Luke Keele, et al. · Journal of the American College of Surgeons
Works count: 14
Citation count: 64
H-index: 6
I10-index: 2
Year
Topic
Type